Molecular Cancer Therapeutics CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blasberg, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blasberg, R. G.
Related Collections
Right arrow Tumor Biology
Right arrow Tumor Biology: Model Organisms and Imaging
Vol. 2, 335-343, March 2003     Molecular Cancer Therapeutics
© 2003 American Association for Cancer Research

Minireview

Molecular Imaging and Cancer

Ronald G. Blasberg1

Department of Neurology and Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021

1 To whom requests for reprints should be addressed, at Department of Neurology Box, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 52, New York, New York 10021

Molecular imaging is a relatively new discipline, which developed over the past decade, initially driven by in situ reporter imaging technology. Noninvasive in vivo molecular imaging developed more recently and is based on magnetic resonance and nuclear (positron emission tomography; gamma camera) and in vivo optical imaging systems. Molecular imaging has its roots in both molecular biology and cell biology, as well as imaging technology. Most current in vivo molecular imaging strategies are "indirect" and involve the coupling of a "reporter/marker gene" with a complimentary "reporter/marker probe." Imaging the level of probe accumulation provides indirect information related to the level of reporter gene expression. Reporter gene constructs are driven by upstream promoter/enhancer elements that function as an "on/off switch"; they can be constitutive, leading to continuous transcription to identify the site and monitor the level and duration of gene (vector) activity. Alternatively, they can be inducible, leading to controlled gene expression, or they can function as a sensor element to monitor the level of endogenous promoters and transcription factors. Three indirect strategies for imaging therapeutic transgenes are discussed. Several examples of imaging endogenous biological processes in animals using reporter constructs, radiolabeled probes, and positron emission tomography imaging are reviewed (p53-dependent gene expression, T-cell receptor-dependent activation of T-lymphocytes, and trafficking of T-lymphocytes). Issues related to the translation of noninvasive molecular imaging technology into the clinic are discussed.




This article has been cited by other articles:


Home page
CirculationHome page
J. Zhang, L. Nie, M. Razavian, M. Ahmed, L. W. Dobrucki, A. Asadi, D. S. Edwards, M. Azure, A. J. Sinusas, and M. M. Sadeghi
Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling
Circulation, November 4, 2008; 118(19): 1953 - 1960.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Keren, C. Zavaleta, Z. Cheng, A. de la Zerda, O. Gheysens, and S. S. Gambhir
Noninvasive molecular imaging of small living subjects using Raman spectroscopy
PNAS, April 15, 2008; 105(15): 5844 - 5849.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. M. Hoffman and S. S. Gambhir
Molecular Imaging: The Vision and Opportunity for Radiology in the Future
Radiology, July 1, 2007; 244(1): 39 - 47.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Ilagan, J. Pottratz, K. Le, L. Zhang, S. G. Wong, R. Ayala, M. Iyer, L. Wu, S. S. Gambhir, and M. Carey
Imaging Mitogen-Activated Protein Kinase Function in Xenograft Models of Prostate Cancer.
Cancer Res., November 15, 2006; 66(22): 10778 - 10785.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. J. Shu, S. Guo, Y. J. Kim, S. M. Shelly, A. Nijagal, P. Ray, S. S. Gambhir, C. G. Radu, and O. N. Witte
Visualization of a primary anti-tumor immune response by positron emission tomography
PNAS, November 29, 2005; 102(48): 17412 - 17417.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
U. De Giorgi and J. Verweij
Imatinib and gastrointestinal stromal tumors: Where do we go from here?
Mol. Cancer Ther., March 1, 2005; 4(3): 495 - 501.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
R. J. Gillies
Noninvasive Imaging of Anticancer Therapy
Mol. Cancer Ther., March 1, 2003; 2(3): 333 - 334.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.